Metabolic syndrome: From the genetics to the pathophysiology

Current Hypertension Reports

Volumn 13, Issue 2, 2011, Pages 149-157

  Sookoian, Silvia ^a   Pirola, Carlos J ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Adolescents; Arterial blood pressure; Cardiometabolic syndrome; Cholesterol; CLOCK; Diabetes; DNA methylation; Dyslipidemia; Epigenetics; Epistasis; Gene; Genetics; Glucose; Hypertension; Insulin; Insulin resistance; miRNAs; Newborns; Obesity; SLC6A4; SLC7A1; Small for gestational age; Systems biology; Triglycerides; Variants

Indexed keywords

CYCLOOXYGENASE 2; FARNESOID X RECEPTOR; MICRORNA; PREGNANE X RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR CLOCK;

CELL DIFFERENTIATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

HUMANS; METABOLIC SYNDROME X; POLYMORPHISM, GENETIC; SYSTEMS BIOLOGY;

EID: 79955974521     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-010-0164-9     Document Type: Review

References (37)

1. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
2. Kahn R: Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007, 115:1806-1810.
3. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
5. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062. (Pubitemid 41338752)
6. Sookoian S, Pirola CJ: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. Ther Adv Cardiovasc Dis 2007, 1:37-47.
7. Zhang C: Novel functions for small RNA molecules. Curr Opin Mol Ther 2009, 11:641-651.
8. Weaver IC: Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off. Epigenetics 2007, 2:22-28.
9. Chen J, Bardes EE, Aronow BJ, et al.: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009, 37:W305-W311. This article demonstrates the bioinformatic tool for gene list functional enrichment, candidate gene prioritization, and identification and prioritization of novel disease candidate genes in the interactome.
10. Sookoian S, Gianotti TF, Schuman M, et al.: Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with type 2 diabetes. Genet Med 2009, 11:338-343.
11. Sookoian S, Gemma C, Pirola CJ: Influence of hepatocyte nuclear factor 4α (HNF4α) gene variants on the risk of type 2 diabetes: a meta-analysis in 49,577 individuals. Mol Genet Metab 2010, 99:80-89.
12. Sookoian S, Gianotti TF, Gemma C, et al.: Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension. J Hypertens 2010, 28:1194-1202.
13. Hindorff LA, Sethupathy P, Junkins HA, et al.: Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
14. Sookoian S, Gemma C, Garcia SI, et al.: Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007, 15:271-276. (Pubitemid 46407306)
15. Sookoian S, Gianotti TF, Gemma C, et al.: Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) 2008, 16:488-491. (Pubitemid 351271937)
16. Duez H, Staels B: Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler Thromb Vasc Biol 2010, 30:1529-1534.
17. Sookoian S, Gemma C, Gianotti TF, et al.: Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr 2008, 87:1606-1615. (Pubitemid 351872621)
18. Sookoian S, Castano G, Gemma C, et al.: Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J Gastroenterol 2007, 13:4242-4248. (Pubitemid 47377164)
19. Li S, Zhao JH, Luan J, et al.: Cumulative effects and predictive value of common obesity-susceptibility variants identified by genomewide association studies. Am J Clin Nutr 2010, 91:184-190.
20. Tomaszewski M, Charchar FJ, Lacka B, et al.: Epistatic interaction between β2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension. Hypertension 2004, 44:689-694. (Pubitemid 39435240)
21. Baessler A, Fischer M, Mayer B, et al.: Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 2007, 16:887-899. (Pubitemid 47062734)
22. Isaacs A, Aulchenko YS, Hofman A, et al.: Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum highdensity lipoprotein cholesterol levels. J Clin Endocrinol Metab 2007, 92:2680-2687. (Pubitemid 47037376)
23. Brisson D, St-Pierre J, Santure M, et al.: Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. Int J Obes (Lond) 2007, 31:1325-1333. (Pubitemid 47172622)
24. Sookoian S, Gianotti TF, Burgueño A, Pirola CJ: Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers. Chronobiol Int 2010, 27:1202-1218.
25. Ling C, Del Guerra S, Lupi R, et al.: Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008, 51:615-622.
26. Gemma C, Sookoian S, Alvarinas J, et al.: Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009, 17:1032-1039.
27. Gemma C, Sookoian S, Dieuzeide G, et al.: Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol Genet Metab 2010, 100:83-87.
28. Gemma C, Sookoian S, Alvarinas J, et al.: Mitochondrial DNA depletion in small- and large-for-gestational-age newborns. Obesity (Silver Spring) 2006, 14:2193-2199. (Pubitemid 46121975)
29. Gianotti TF, Sookoian S, Dieuzeide G, et al.: A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity 2008, 16:1591-1595. (Pubitemid 351915123)
30. Ling C, Groop L: Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009, 58:2718-2725.
31. Sethupathy P, Borel C, Gagnebin M, et al.: Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007, 81:405-413. (Pubitemid 47236088)
32. Sookoian S, Castano G, Garcia SI, et al.: A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension. Am J Gastroenterol 2005, 100:636-642. (Pubitemid 40487564)
33. Yang Z, Kaye DM: Mechanistic insights into the link between a polymorphism of the 3?UTR of the SLC7A1 gene and hypertension. Hum Mutat 2009, 30:328-333.
34. Yang Z, Venardos K, Jones E, et al.: Identification of a novel polymorphism in the 3′UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation 2007, 115:1269-1274. (Pubitemid 46594771)
35. Rayner KJ, Suarez Y, Davalos A, et al.: MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573. The authors demonstrated that miR-33 appears to regulate both HDL biogenesis in the liver and cellular cholesterol efflux.
36. Peter ME: Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010, 29:2161-2164.
37. Warde-Farley D, Donaldson SL, Comes O, et al: The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010:W214-220.